Your browser doesn't support javascript.
loading
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Dörner, Thomas; Kaul, Martin; Szántó, Antónia; Tseng, Jui-Cheng; Papas, Athena S; Pylvaenaeinen, Ilona; Hanser, Malika; Abdallah, Nasri; Grioni, Andrea; Santos Da Costa, Aida; Ferrero, Enrico; Gergely, Peter; Hillenbrand, Rainer; Avrameas, Alexandre; Cenni, Bruno; Siegel, Richard M.
Afiliação
  • Dörner T; Dept. Med./Rheumatology and Clinical Immunology, Charite Univ. Hospital, Berlin, Germany thomas.doerner@charite.de.
  • Kaul M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Szántó A; Independent consultant, Neustadt, Germany.
  • Tseng JC; Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Papas AS; Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
  • Pylvaenaeinen I; Oral Medicine, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.
  • Hanser M; Early Development Analytics, Novartis Pharmaceutical AG, Basel, Switzerland.
  • Abdallah N; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Grioni A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Santos Da Costa A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Ferrero E; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Gergely P; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Hillenbrand R; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Avrameas A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Cenni B; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Siegel RM; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Ann Rheum Dis ; 83(3): 360-371, 2024 Feb 15.
Article em En | MEDLINE | ID: mdl-37932009
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Síndrome de Sjogren Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Síndrome de Sjogren Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido